已收盤 02-06 16:00:00 美东时间
+0.570
+7.29%
今日重点评级关注:HC Wainwright & Co.:维持Soleno Therapeutics"买入"评级,目标价从110美元升至120美元;富国银行:维持Soleno Therapeutics"超配"评级,目标价从106美元升至114美元
01-21 11:42
Across the recent three months, 5 analysts have shared their insights on RxSigh...
01-21 04:00
Piper Sandler analyst Adam Maeder maintains RxSight (NASDAQ:RXST) with a Neutral and raises the price target from $10 to $11.
01-20 21:17
U.S. stocks were lower, with the Dow Jones index falling around 200 points on M...
01-12 23:07
RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that Shelley Thunen, the Company's Chief Financial
2025-12-23 06:16
今日重点评级关注:B. Riley证券:维持Seabridge Gold"买入"评级,目标价从50美元升至65美元;HC Wainwright & Co.:维持TRX Gold"买入"评级,目标价从1.2美元升至1.4美元
2025-12-03 09:58
Morgan Stanley analyst Patrick Wood maintains RxSight (NASDAQ:RXST) with a Equal-Weight and raises the price target from $9 to $10.
2025-12-03 01:53
U.S. stocks were mixed, with the Dow Jones gaining around 150 points on Friday....
2025-11-22 00:14
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价;Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
2025-11-07 10:14
Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and raises the price target from $11 to $12.
2025-11-06 18:12